Prognosis of Differentiated Thyroid Carcinoma with Initial Distant Metastasis: A Multicenter Study in Korea

다국어 초록 (Multilingual Abstract)

Background: Most patients with differentiated thyroid cancer (DTC) have a favorable prognosis. However, patients with DTC and initial distant metastasis have not been commonly found, and their clinical characteristics have seldom been reported. In this study, we analyzed the clinical features and prognosis of patients with DTC and initial distant metastasis in Korea.
Methods: We retrospectively reviewed the clinical data of 242 patients with DTC and initial distant metastasis treated from 1994 to 2013, collected from five tertiary hospitals in Korea.
Results: The patients’ median age was 51 years, and 65% were women. They were followed for a median of 7 years. Lung was the most common site of distant metastasis: only lung 149 patients (62%), only bone 49 (20%), other single site one (pleura), and combined sites 43 (40 were lung and bone, two were bone and other site, and one was lung and other site). At the time of diagnosis, 50 patients (21%) had non-radioactive iodine (RAI) avidity. Five-year disease-specific survival (DSS) was 85% and 10-year DSS was 68%, which were better than those in previous studies. After multivariate analysis, old age, male sex, metastatic site, and histologic type (follicular type) were significant factors for poor prognosis. However, negative RAI avidity status was not a significant prognostic factor after adjusting for other variables.
Conclusion:The prognosis of Korean patients with DTC and initial distant metastasis was better than in previous studies. Old age, male sex, metastasis site, and histologic type were significant prognostic factors.

참고문헌 (Reference)

1 Ahn HS, "thyroid cancer screening in South Korea increases detection of papillary cancers with no impact on other subtypes or thyroid cancer mortality" 26 : 1535-1540, 2016

2 Nixon IJ, "The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland" 22 : 884-889, 2012

3 Lubitz CC, "The changing landscape of papillary thyroid cancer: epidemiology, management, and the implications for patients" 122 : 3754-3759, 2016

4 Brose MS, "Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial" 384 : 319-328, 2014

5 Massin JP, "Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment" 53 : 982-992, 1984

6 Shoup M, "Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma" 197 : 191-197, 2003

7 Pires BP, "Prognostic factors for early and long-term remission in pediatric differentiated thyroid carcinoma: the role of sex, age, clinical presentation, and the newly proposed American Thyroid Association risk stratification system" 26 : 1480-1487, 2016

8 Kim H, "Patterns of initial recurrence in completely resected papillary thyroid carcinoma" 27 : 908-914, 2017

9 Durante C, "Papillary thyroid cancer: time course of recurrences during postsurgery surveillance" 98 : 636-642, 2013

10 Schlumberger M, "Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma" 63 : 960-967, 1986

11 Durante C, "Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy" 91 : 2892-2899, 2006

12 Schlumberger M, "Lenvatinib versus placebo in radioiodine-refractory thyroid cancer" 372 : 621-630, 2015

13 Olaleye O, "Increasing incidence of differentiated thyroid cancer in South East England: 1987-2006" 268 : 899-906, 2011

14 Lang BH, "Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis" 20 : 1329-1335, 2013

15 Ruegemer JJ, "Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables" 67 : 501-508, 1988

16 Shaha AR, "Distant metastases from thyroid and parathyroid cancer" 63 : 243-249, 2001

17 전민지, "Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study" 대한내분비학회 32 (32): 434-441, 2017

18 Lee J, "Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors" 251 : 114-119, 2010

19 Shaha AR, "Differentiated thyroid cancer presenting initially with distant metastasis" 174 : 474-476, 1997

20 Sampson E, "Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis" 110 : 1451-1456, 2007

21 Roti E, "Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients" 91 : 2171-2178, 2006

22 Cho BY, "Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades" 23 : 797-804, 2013

23 Pittas AG, "Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients" 10 : 261-268, 2000

24 Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: what is new and what has changed?" 123 : 372-381, 2017